Management of COVID-19 Patient in Cardiac Surgery with Cardiopulmonary Bypass.
AJTES Vol 5, No 1, January 2021
Pdf Full Text


Cardiac surgery
Cytokine storm

How to Cite

Ibrahimi, A., Kuci, S., Bejko, E., Llazo, S., Goga, M., Bulku, E., Burimi, J., Dumani, S., Likaj, E., Zeitani, J., & Prifti, E. (2021). Management of COVID-19 Patient in Cardiac Surgery with Cardiopulmonary Bypass. Albanian Journal of Trauma and Emergency Surgery, 5(1), 779-783.


Introduction; The diagnosis of COVID-19 is quite challenging due to the inconsistent correlation between laboratory findings, radiological imaging, and the clinical picture and contact history of the patient. The patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) face double risk because CBP triggers an intense inflammatory response and the leading cause of mortality in COVID-19 patients is “cytokine storm”. In our institution 15 confirmed cases operated on with open-heart surgery. 9 cases isolated CABG, 4 cases valvular combined with CABG, and 1 valvular disease.

Materials and method; All patients undergoing elective or urgent cardiac surgery at “Mother Theresa” ’s Hospital from 11 March to 30 November 2020 were included in this study. Patients diagnosed with COVID-19 infection via positive throat swab taken due to clinical suspicion postoperatively were reviewed. Patients characteristics, type of intervention, date of COVID-19 diagnosis.

Results: 9 patients (72%) normal recovery, no respiratory failure, only 3-5 days of fever (max 39,4). 3 of them a moderate respiratory failure. 3 patients with severe respiratory failure. Only 3 deaths (26,6%).

Recommendation: It's important to a preoperative screening for COVID-19 patients.

The outcome of cardiac surgical patients who contracted COVID-19 infection perioperatively is extremely poor. Aggressive respiratory assistance (early intubation), high doses of corticosteroids, and anticoagulation, better results.
Pdf Full Text


1. Head SJ, da Costa BR, Beumer B, et al. Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery 2017 Aug 1;52(2):206e17
2. Morgan CD, Sykora K, Naylor CD. Steering Committee of the Cardiac Care Network of Ontario. Analysis of deaths while waiting for cardiac surgery among 29 293 consecutive patients in Ontario, Canada. Heart 1998 Apr 1;79(4):345e9
3. Young RS, O'Regan DJ. Cardiac surgical theatre traffic: time for traffic calming measures? Interactive cardiovascular and thoracic surgery 2010 Apr 1;10(4):526e9.
4. Editorial Br J Anaesth 2020 May;124(5):497-501. doi: 10.1016/j.bja.2020.02.008. Epub 2020 Feb 27. Outbreak of a new coronavirus: what anesthetists should know Philip W H Peng 1, Pak- Leung Ho 2, Susy S Hota 3 Affiliations expand PMID: 32115186 PMCID: PMC7124191DOI: 10.1016 /j.bja.2020.02.008 Free PMC article
5. Zhao S, Ling K, Yan H, et al. Anesthetic management of patients with suspected 2019 novel coronavirus infection during emergency procedures. Journal of Cardiothoracic and Vascular Anesthesia 2020 Feb 28.
6. Outcomes of patients diagnosed with COVID-19 in the early postoperative period following cardiac surgery Martin T. Yates, Damian Balmforth, Ana Lopez-Marco, Rakesh Uppal and Aung Y. OoInteractive CardioVascular and Thoracic Surgery 31 (2020) 483–485 doi:10.1093/icvts/ivaa143 Advance Access publication 13 August 2020
7. Gaudriot B, Uhel F, Gregoire M, et al. Immune dysfunction after cardiac surgery with cardiopulmonary bypass: beneficial effects of maintaining mechanical ventilation. Shock 2015 Sep 1;44(3):228e33
8. Chen C, Zhang XR, Ju ZY, et al. Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies. Zhonghua Shao Shang Za zhi¼ Zhonghua Shao Shang zazhi¼ Chin Journal of Burns 2020 Mar 1;36: E005
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.